Shares of drugmaker Pfizer PFE.N rise 5% to $24.68
Raises FY adjusted EPS guidance by 10 cents at midpoint to $2.90-$3.10 range
Q2 adjusted EPS of 78 cents vs. estimate of 58 cents - data compiled by LSEG
New guidance absorbs almost a 20 cent one-time hit from licensing deal with China's 3SBio 1530.HK
Analysts, on average, expect 2025 profit of $3.02 per share - data compiled by LSEG
Stock down 7.6% YTD